Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Movement Disorder Society of Australia and New Zealand (MDSANZ) is a professional organization dedicated to the study and treatment of movement disorders. It serves as the premier representative body for clinicians, scientists, and healthcare professionals specializing in conditions such as Parkinson's disease, dystonia, and tremor within the Australasian region. The society facilitates clinical research, provides specialized education and training, and promotes best practices in patient care. MDSANZ also collaborates with international bodies like the International Parkinson and Movement Disorder Society (MDS) to advance the field of neurology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Movement Disorder Society of Australia and New Zealand.